The AIM with Immunotherapy Initiative – Home › Forums › Immunotherapy › Side-effect management › ASCO/NCCN guidlines now out › Reply To: ASCO/NCCN guidlines now out
February 23, 2018 at 5:53 pm #4713
Expert NurseMollie Reed
I agree with your statement, Krista…..there is certainly no one-size-fits-all approach to managing IMAEs. Some AEs definitely warrant longer courses of steroids than others. For example, rashes usually respond very quickly to steroids, and in my experience, wouldn’t warrant 6 weeks of steroids. And, you’re right on par with the endocrinopathies that don’t warrant interruption at all.